Last reviewed · How we verify
Autologous Adipose Derieved MSCs — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Autologous Adipose Derieved MSCs (Autologous Adipose Derieved MSCs) — Kasiak Research Pvt. Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Autologous Adipose Derieved MSCs TARGET | Autologous Adipose Derieved MSCs | Kasiak Research Pvt. Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Autologous Adipose Derieved MSCs CI watch — RSS
- Autologous Adipose Derieved MSCs CI watch — Atom
- Autologous Adipose Derieved MSCs CI watch — JSON
- Autologous Adipose Derieved MSCs alone — RSS
Cite this brief
Drug Landscape (2026). Autologous Adipose Derieved MSCs — Competitive Intelligence Brief. https://druglandscape.com/ci/autologous-adipose-derieved-mscs. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab